ICON PLC
NASDAQ:ICLR
Relative Value
The Relative Value of one ICLR stock under the Base Case scenario is 430.01 USD. Compared to the current market price of 301.57 USD, ICON PLC is Undervalued by 30%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ICLR Competitors Multiples
ICON PLC Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
IE |
ICON PLC
NASDAQ:ICLR
|
24.9B USD | 3.1 | 40.6 | 17.3 | 26.9 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.5B USD | 5.2 | 37 | 22.8 | 33.4 | ||
US |
Danaher Corp
NYSE:DHR
|
182.2B USD | 4.2 | 22.6 | 16.4 | 20.3 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
42.3B USD | 2.8 | 31.2 | 16.9 | 26.1 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.6B USD | 6 | 32.8 | 26.3 | 31.6 | ||
CH |
Lonza Group AG
SIX:LONN
|
37B CHF | 5.5 | 56.5 | 19.4 | 28.5 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 15 | 64.8 | 34.2 | 49.2 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.6B USD | 7 | 33.8 | 23.6 | 26.3 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.6B USD | 9 | 44.8 | 30.6 | 36.6 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
18.7B EUR | 6.9 | 73.5 | 31.7 | 52 | ||
US |
Illumina Inc
NASDAQ:ILMN
|
19.7B USD | 4.4 | -17 | 56.7 | -265.5 |